Dalrada Technology Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Dalrada Technology Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $20.30M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $19.84M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $29.74M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $19.27M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $3.41M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $1.18M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $72.2K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $0 | Jan 30, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $20.30M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $19.84M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $29.74M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $19.27M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $3.41M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $1.18M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $72.2K | Oct 15, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.30M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $984.0K | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $9.06M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $10.51M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $934.7K | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $552.2K | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | ($2.8K) | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $0 | Jan 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($24.65M) | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | ($28.95M) | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | ($20.29M) | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | ($14.10M) | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $91.4K | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | ($2.47M) | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $365.9K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | ($1.04M) | Jan 30, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($20.46M) | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | ($26.84M) | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | ($20.96M) | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | ($10.44M) | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | ($8.57M) | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | ($2.69M) | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | ($1.05M) | Oct 15, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $0 | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $120.0K | Jun 6, 2025 |
| FY2022 | Jun 30, 2022 | $657.0K | Nov 1, 2022 |
| FY2022 | Jun 30, 2021 | $520.5K | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $472.0K | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $50.1K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $0 | Jan 30, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $23.02M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $27.82M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $29.47M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $20.07M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $8.98M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $2.77M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $721.8K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $92.0K | Jan 30, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($17.97M) | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | ($7.87M) | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | ($4.61M) | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | ($10.35M) | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | ($5.58M) | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | ($2.39M) | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | ($822.4K) | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | ($32.0K) | Jan 30, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $374.5K | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $434.8K | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $693.2K | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $640.2K | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $358.0K | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $194.1K | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $5.5K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $0 | Jan 30, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $18.36M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $23.07M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $25.17M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $22.42M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $4.70M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $2.78M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $53.2K | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $5.5K | Jan 30, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $25.05M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $19.72M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $20.92M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | $37.38M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | $18.11M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | $17.92M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $13.69M | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | $14.05M | Jan 30, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($6.75M) | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $3.44M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | $4.11M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | ($15.43M) | Oct 19, 2023 |
| FY2020 | Jun 30, 2020 | ($15.14M) | Oct 15, 2020 |
| FY2020 | Jun 30, 2019 | ($13.64M) | Oct 15, 2020 |
| FY2020 | Jun 30, 2018 | ($14.04M) | Oct 15, 2020 |
| FY2019 | Jun 30, 2017 | ($13.00M) | Jan 30, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.53M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $4.18M | Sep 30, 2025 |
| FY2025 | Jun 30, 2023 | $3.80M | Sep 30, 2025 |
| FY2024 | Jun 30, 2022 | $4.25M | Jun 6, 2025 |
| FY2023 | Jun 30, 2021 | $736.5K | Oct 19, 2023 |
| FY2021 | Jun 30, 2020 | $143.2K | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | $0 | Oct 15, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($195.32M) | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | ($170.68M) | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | ($141.73M) | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | ($121.44M) | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | ($107.34M) | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | ($107.43M) | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | ($104.96M) | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | ($105.33M) | Jan 30, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $172.8K | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | $501.9K | Sep 30, 2025 |
| FY2025 | Jun 30, 2023 | $812.8K | Sep 30, 2025 |
| FY2024 | Jun 30, 2022 | $772.1K | Jun 6, 2025 |
| FY2023 | Jun 30, 2021 | $110.3K | Oct 19, 2023 |
| FY2021 | Jun 30, 2020 | $75.2K | Oct 13, 2021 |
| FY2021 | Jun 30, 2019 | $963 | Oct 13, 2021 |
| FY2020 | Jun 30, 2018 | $5.5K | Oct 15, 2020 |
| FY2019 | Jun 30, 2017 | $0 | Jan 30, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | 0 | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Jan 30, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | 0 | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Jan 30, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 120.16M | Sep 30, 2025 |
| FY2025 | Jun 30, 2024 | 97.18M | Sep 30, 2025 |
| FY2024 | Jun 30, 2023 | 88.70M | Jun 6, 2025 |
| FY2023 | Jun 30, 2022 | 72.17M | Oct 19, 2023 |
| FY2022 | Jun 30, 2021 | 73.84M | Nov 1, 2022 |
| FY2021 | Jun 30, 2020 | 68.46M | Oct 13, 2021 |
| FY2020 | Jun 30, 2019 | 48.28M | Oct 15, 2020 |
| FY2019 | Jun 30, 2018 | 47.28M | Jan 30, 2020 |